Most Recent
A judge has declined to quash the indictment in a high-profile criminal case over a $2.5 billion ANZ share placement but sent prosecutors back to the drawing board to remedy its defects, calling the state of affairs "a complete shemozzle".
JPMorgan's general counsel for Australia and New Zealand was allowed to sit in on witness interviews during an ACCC cartel investigation into ANZ's $2.5 billion share placement despite allegedly being involved in the cartel conduct, a judge has heard.
A judge has rejected part of IVF provider Virtus Health’s bid for redactions in a recent decision from the court temporarily blocking the company from purchasing rival Adora Fertility, saying some of the confidentiality claims were “staggering” and “border on ridiculous.”
BlueScope general manager Jason Ellis made executives of a steel distributor “extremely uncomfortable” in a meeting where he presented the steel giant’s price list, a court hearing the ACCC’s price-fixing case was told Monday.
Thomson Geer is giving all staff a 10 per cent pay bump, less than a week after Big Six law firm Gilbert + Tobin announced similar measures amid tight competition for talent in the legal market.
Big Six law firm Gilbert + Tobin has announced it will give all legal staff who have been with the business since July a ten per cent pay rise and increase parental leave to 26 weeks to lure talent in a competitive market.
Legislation capping litigation funder returns in class actions to 30 per cent and requiring group members to sign up to funding schemes has been introduced to federal parliament despite widespread criticism.
BlueScope Steel general manager Jason Ellis was not an honest witness and did not express genuine regret when he apologised for obstructing an ACCC investigation, a court hearing the regulator’s price-fixing case was told Tuesday.
The Australian Competition and Consumer Commission has won an injunction to stop Virtus from completing the purchase of rival Adora Fertility until a court has ruled on the competition regulator's challenge to the acquisition.
IVF provider Virtus Health would be “the author of its own fate” if its proposed acquisition of rival Adora Fertility flopped, a judge has said in hearing the ACCC’s bid for a temporary injunction blocking completion of the planned purchase.